Griffiths CEM - Search Results

1

Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study.

Wilkinson N, Tsakok T, Dand N, Bloem K, Duckworth M, Baudry D, Pushpa-Rajah A, Griffiths CEM, Reynolds NJ, Barker J, Warren RB, Burden AD, Rispens T, Stocken D, Smith C; BSTOP study group; PSORT consortium. Wilkinson N, et al. Among authors: griffiths cem. J Invest Dermatol. 2019 Jan;139(1):115-123. doi: 10.1016/j.jid.2018.07.028. Epub 2018 Aug 18. J Invest Dermatol. 2019. PMID: 30130616 Free PMC article.

2

A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy.

Fortune DG, Richards HL, Kirby B, Bowcock S, Main CJ, Griffiths CE. Fortune DG, et al. Br J Dermatol. 2002 Mar;146(3):458-65. doi: 10.1046/j.1365-2133.2002.04622.x. Br J Dermatol. 2002. PMID: 11952546 Clinical Trial.

3

Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial.

Bhushan M, Bleiker TO, Ballsdon AE, Allen MH, Sopwith M, Robinson MK, Clarke C, Weller RP, Graham-Brown RA, Keefe M, Barker JN, Griffiths CE. Bhushan M, et al. Br J Dermatol. 2002 May;146(5):824-31. doi: 10.1046/j.1365-2133.2002.04743.x. Br J Dermatol. 2002. PMID: 12000379 Clinical Trial.

4

Patients' strategies for coping with psoriasis.

Fortune DG, Richards HL, Main CJ, Griffiths CE. Fortune DG, et al. Clin Exp Dermatol. 2002 May;27(3):177-84. doi: 10.1046/j.1365-2230.2002.01055.x. Clin Exp Dermatol. 2002. PMID: 12072002

5

Resetting the research agenda for psoriasis.

Chalmers RJ, Griffiths CE. Chalmers RJ, et al. J Invest Dermatol. 2003 May;120(5):ix-x. doi: 10.1046/j.1523-1747.2003.12152.x. J Invest Dermatol. 2003. PMID: 12713600 Free article. No abstract available.

6

Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy.

Fortune DG, Richards HL, Kirby B, McElhone K, Markham T, Rogers S, Main CJ, Griffiths CE. Fortune DG, et al. Arch Dermatol. 2003 Jun;139(6):752-6. doi: 10.1001/archderm.139.6.752. Arch Dermatol. 2003. PMID: 12810506

7

A Crohn's disease-associated insertion polymorphism (3020insC) in the NOD2 gene is not associated with psoriasis vulgaris, palmo-plantar pustular psoriasis or guttate psoriasis.

Young C, Allen MH, Cuthbert A, Ameen M, Veal C, Leman J, Burden AD, Kirby B, Griffiths CE, Trembath RC, Mathew CG, Barker JN. Young C, et al. Exp Dermatol. 2003 Aug;12(4):506-9. doi: 10.1034/j.1600-0625.2002.120420.x. Exp Dermatol. 2003. PMID: 12930309

8

Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis.

Donn RP, Plant D, Jury F, Richards HL, Worthington J, Ray DW, Griffiths CE. Donn RP, et al. J Invest Dermatol. 2004 Sep;123(3):484-7. doi: 10.1111/j.0022-202X.2004.23314.x. J Invest Dermatol. 2004. PMID: 15304087 Free article.

9

The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis.

Allen MH, Ameen H, Veal C, Evans J, Ramrakha-Jones VS, Marsland AM, Burden AD, Griffiths CE, Trembath RC, Barker JN. Allen MH, et al. J Invest Dermatol. 2005 Jan;124(1):103-6. doi: 10.1111/j.0022-202X.2004.23511.x. J Invest Dermatol. 2005. PMID: 15654960 Free article.

10

British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005.

Smith CH, Anstey AV, Barker JN, Burden AD, Chalmers RJ, Chandler D, Finlay AY, Griffiths CE, Jackson K, McHugh NJ, McKenna KE, Reynolds NJ, Ormerod AD; British Association of Dermatologists. Smith CH, et al. Br J Dermatol. 2005 Sep;153(3):486-97. doi: 10.1111/j.1365-2133.2005.06893.x. Br J Dermatol. 2005. PMID: 16120132 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

577 results

Search Page